PositiveID Corporation an emerging growth company and developer of
airborne bio-threat detection systems for America's homeland defense industry
as well as advanced technologies for rapid medical testing and diabetes
management, today announced it has entered into a license agreement and a
teaming agreement with The Boeing Company BA, including a license fee
to PositiveID of $2.5 million.
The license agreement provides Boeing the exclusive license to manufacture and
sell PositiveID's M-BAND (Microfluidics-based Bioagent Networked Detector)
airborne bio-threat detector for the U.S. Department of Homeland Security's
("DHS") BioWatch Generation 3 opportunity, as well as other opportunities
(government or commercial) that may arise in the North American market. Under
the teaming agreement, PositiveID will retain exclusive rights to serve as the
reagent and assay supplier of the M-BAND systems to Boeing in the U.S. market.
PositiveID will also retain the right to sell M-BAND units, reagents and
assays in international markets.
PositiveID's M-BAND, developed under contract for DHS Science and Technology
Division, is a bioaerosol monitor with fully integrated systems with sample
collection, processing and detection modules that continuously analyze air
samples for the detection of bacteria, viruses, and toxins. Results from
individual M-BAND instruments are reported via a secure wireless network in
real time to give an accurate and up to date status for fielded instruments in
the aggregate.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in